171 related articles for article (PubMed ID: 30160786)
1. Caspase-independent hepatocyte death: A result of the decrease of lysophosphatidylcholine acyltransferase 3 in non-alcoholic steatohepatitis.
Kakisaka K; Suzuki Y; Fujiwara Y; Suzuki A; Kanazawa J; Takikawa Y
J Gastroenterol Hepatol; 2019 Jul; 34(7):1256-1262. PubMed ID: 30160786
[TBL] [Abstract][Full Text] [Related]
2. Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes.
Hirsova P; Ibrahim SH; Krishnan A; Verma VK; Bronk SF; Werneburg NW; Charlton MR; Shah VH; Malhi H; Gores GJ
Gastroenterology; 2016 Apr; 150(4):956-67. PubMed ID: 26764184
[TBL] [Abstract][Full Text] [Related]
3. Integrin β
Guo Q; Furuta K; Lucien F; Gutierrez Sanchez LH; Hirsova P; Krishnan A; Kabashima A; Pavelko KD; Madden B; Alhuwaish H; Gao Y; Revzin A; Ibrahim SH
J Hepatol; 2019 Dec; 71(6):1193-1205. PubMed ID: 31433301
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of lysophosphatidylcholine-induced hepatocyte lipoapoptosis.
Kakisaka K; Cazanave SC; Fingas CD; Guicciardi ME; Bronk SF; Werneburg NW; Mott JL; Gores GJ
Am J Physiol Gastrointest Liver Physiol; 2012 Jan; 302(1):G77-84. PubMed ID: 21995961
[TBL] [Abstract][Full Text] [Related]
5. The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis.
Barreyro FJ; Holod S; Finocchietto PV; Camino AM; Aquino JB; Avagnina A; Carreras MC; Poderoso JJ; Gores GJ
Liver Int; 2015 Mar; 35(3):953-66. PubMed ID: 24750664
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease.
Dongiovanni P; Meroni M; Baselli GA; Bassani GA; Rametta R; Pietrelli A; Maggioni M; Facciotti F; Trunzo V; Badiali S; Fargion S; Gatti S; Valenti L
Clin Sci (Lond); 2017 Jun; 131(12):1301-1315. PubMed ID: 28468951
[TBL] [Abstract][Full Text] [Related]
7. Myristic acid potentiates palmitic acid-induced lipotoxicity and steatohepatitis associated with lipodystrophy by sustaning de novo ceramide synthesis.
Martínez L; Torres S; Baulies A; Alarcón-Vila C; Elena M; Fabriàs G; Casas J; Caballeria J; Fernandez-Checa JC; García-Ruiz C
Oncotarget; 2015 Dec; 6(39):41479-96. PubMed ID: 26539645
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidylcholine acyltransferase 3 knockdown-mediated liver lysophosphatidylcholine accumulation promotes very low density lipoprotein production by enhancing microsomal triglyceride transfer protein expression.
Li Z; Ding T; Pan X; Li Y; Li R; Sanders PE; Kuo MS; Hussain MM; Cao G; Jiang XC
J Biol Chem; 2012 Jun; 287(24):20122-31. PubMed ID: 22511767
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of a major liver lysophosphatidylcholine acyltransferase.
Zhao Y; Chen YQ; Bonacci TM; Bredt DS; Li S; Bensch WR; Moller DE; Kowala M; Konrad RJ; Cao G
J Biol Chem; 2008 Mar; 283(13):8258-65. PubMed ID: 18195019
[TBL] [Abstract][Full Text] [Related]
10. Cellular cholesterol accumulation modulates high fat high sucrose (HFHS) diet-induced ER stress and hepatic inflammasome activation in the development of non-alcoholic steatohepatitis.
Bashiri A; Nesan D; Tavallaee G; Sue-Chue-Lam I; Chien K; Maguire GF; Naples M; Zhang J; Magomedova L; Adeli K; Cummins CL; Ng DS
Biochim Biophys Acta; 2016 Jul; 1861(7):594-605. PubMed ID: 27090939
[TBL] [Abstract][Full Text] [Related]
11. Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis.
Afonso MB; Rodrigues PM; Carvalho T; Caridade M; Borralho P; Cortez-Pinto H; Castro RE; Rodrigues CM
Clin Sci (Lond); 2015 Oct; 129(8):721-39. PubMed ID: 26201023
[TBL] [Abstract][Full Text] [Related]
12. A novel assay for measuring recombinant human lysophosphatidylcholine acyltransferase 3 activity.
Du X; Hu J; Zhang Q; Liu Q; Xiang X; Dong J; Lou B; He S; Gu X; Cao Y; Li Y; Ding T
FEBS Open Bio; 2019 Oct; 9(10):1734-1743. PubMed ID: 31376210
[TBL] [Abstract][Full Text] [Related]
13. Liver-specific overexpression of LPCAT3 reduces postprandial hyperglycemia and improves lipoprotein metabolic profile in mice.
Cash JG; Hui DY
Nutr Diabetes; 2016 Apr; 6(4):e206. PubMed ID: 27110687
[TBL] [Abstract][Full Text] [Related]
14. Membrane phospholipid remodeling modulates nonalcoholic steatohepatitis progression by regulating mitochondrial homeostasis.
Tian Y; Jellinek MJ; Mehta K; Seok SM; Kuo SH; Lu W; Shi R; Lee R; Lau GW; Kemper JK; Zhang K; Ford DA; Wang B
Hepatology; 2024 Apr; 79(4):882-897. PubMed ID: 36999536
[TBL] [Abstract][Full Text] [Related]
15. [Metformin prevents non-alcoholic fatty liver disease in rats: role of phospholipase A2/lysophosphatidylcholine lipoapoptosis pathway in hepatocytes].
Huang Y; Fu JF; Shi HB; Liu LR
Zhonghua Er Ke Za Zhi; 2011 Feb; 49(2):139-45. PubMed ID: 21426695
[TBL] [Abstract][Full Text] [Related]
16. Palmitic acid induces autophagy in hepatocytes via JNK2 activation.
Tu QQ; Zheng RY; Li J; Hu L; Chang YX; Li L; Li MH; Wang RY; Huang DD; Wu MC; Hu HP; Chen L; Wang HY
Acta Pharmacol Sin; 2014 Apr; 35(4):504-12. PubMed ID: 24608675
[TBL] [Abstract][Full Text] [Related]
17. Caspase-11-Mediated Hepatocytic Pyroptosis Promotes the Progression of Nonalcoholic Steatohepatitis.
Zhu Y; Zhao H; Lu J; Lin K; Ni J; Wu G; Tang H
Cell Mol Gastroenterol Hepatol; 2021; 12(2):653-664. PubMed ID: 33894425
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 expression in hepatocytes attenuates non-alcoholic steatohepatitis and liver fibrosis in mice.
Motiño O; Agra N; Brea Contreras R; Domínguez-Moreno M; García-Monzón C; Vargas-Castrillón J; Carnovale CE; Boscá L; Casado M; Mayoral R; Valdecantos MP; Valverde ÁM; Francés DE; Martín-Sanz P
Biochim Biophys Acta; 2016 Sep; 1862(9):1710-23. PubMed ID: 27321932
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidylcholine acyltransferase 1 altered phospholipid composition and regulated hepatoma progression.
Morita Y; Sakaguchi T; Ikegami K; Goto-Inoue N; Hayasaka T; Hang VT; Tanaka H; Harada T; Shibasaki Y; Suzuki A; Fukumoto K; Inaba K; Murakami M; Setou M; Konno H
J Hepatol; 2013 Aug; 59(2):292-9. PubMed ID: 23567080
[TBL] [Abstract][Full Text] [Related]
20. Identification of Hepatic Lysophosphatidylcholine Acyltransferase 3 as a Novel Target Gene Regulated by Peroxisome Proliferator-activated Receptor δ.
Singh AB; Liu J
J Biol Chem; 2017 Jan; 292(3):884-897. PubMed ID: 27913621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]